EP1087730A1 - Minimalinvasives messinstrument für einen herzventilverankerungsring - Google Patents
Minimalinvasives messinstrument für einen herzventilverankerungsringInfo
- Publication number
- EP1087730A1 EP1087730A1 EP99928786A EP99928786A EP1087730A1 EP 1087730 A1 EP1087730 A1 EP 1087730A1 EP 99928786 A EP99928786 A EP 99928786A EP 99928786 A EP99928786 A EP 99928786A EP 1087730 A1 EP1087730 A1 EP 1087730A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- sizer
- handle
- sizing portion
- sizing
- coupling portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004513 sizing Methods 0.000 claims abstract description 82
- 230000008878 coupling Effects 0.000 claims abstract description 45
- 238000010168 coupling process Methods 0.000 claims abstract description 45
- 238000005859 coupling reaction Methods 0.000 claims abstract description 45
- 230000003601 intercostal effect Effects 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 28
- 210000004115 mitral valve Anatomy 0.000 claims description 16
- 210000000591 tricuspid valve Anatomy 0.000 claims description 6
- 238000005452 bending Methods 0.000 claims description 2
- 230000002093 peripheral effect Effects 0.000 claims description 2
- 210000003734 kidney Anatomy 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 abstract description 12
- 230000003287 optical effect Effects 0.000 abstract description 5
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 210000001765 aortic valve Anatomy 0.000 description 7
- 230000002950 deficient Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 210000005240 left ventricle Anatomy 0.000 description 5
- 238000002324 minimally invasive surgery Methods 0.000 description 5
- 206010002906 aortic stenosis Diseases 0.000 description 4
- 210000003709 heart valve Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 208000006887 mitral valve stenosis Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 208000020128 Mitral stenosis Diseases 0.000 description 3
- 210000000709 aorta Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 201000003068 rheumatic fever Diseases 0.000 description 3
- 210000000115 thoracic cavity Anatomy 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 241000208011 Digitalis Species 0.000 description 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 229940030606 diuretics Drugs 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 238000012978 minimally invasive surgical procedure Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 210000003102 pulmonary valve Anatomy 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- 206010002915 Aortic valve incompetence Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000035211 Heart Murmurs Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010027727 Mitral valve incompetence Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000034713 Spontaneous Rupture Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 201000002064 aortic valve insufficiency Diseases 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 238000013158 balloon valvuloplasty Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 210000005244 lower chamber Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000013208 measuring procedure Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 208000005907 mitral valve insufficiency Diseases 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000002278 reconstructive surgery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2496—Devices for determining the dimensions of the prosthetic valve to be implanted, e.g. templates, sizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
Definitions
- the present invention is directed to apparatus and associated methods for measuring the size of a heart valve annulus during annuloplasty surgery.
- Heart valve annuluses are measured in order to select a properly sized annuloplasty ring which is then implanted to repair a defective valve of the heart, such as the mitral valve or the tricuspid valve.
- the heart has four valves — two on the right (the pulmonary and tricuspid) and two on the left (the aortic and mitral) — that control the flow of blood through the chambers of the heart and out to the body. Although any of these valves may fail to function properly, disease most commonly affects the valves on the left side of the heart.
- the valves may narrow (called stenosis); the valves may not close all the way (causing a backflow of blood called regurgitation); or the valves may close incorrectly (called prolapse).
- a heart murmur represents the sound that a leaky or narrowed heart valve makes as blood moves through it.
- Aortic stenosis is a narrowing of the aortic valve, through which blood flows from the left ventricle of the heart to the aorta, the major artery whose branches supply blood to various parts of the body. Sometimes this narrowness is a congenital (i.e., inborn) defect, but more often the valve narrows as a consequence of aging, or of infections, such as rheumatic fever.
- Aortic stenosis results in the left ventricle having to work harder and harder to push blood out. As this occurs, the muscular walls of the ventricle thicken, increasing their requirement for oxygen.
- Symptoms of aortic stenosis include chest pain when the oxygen needs exceed the supply from the coronary arteries; fainting (syncope), if the valve becomes very narrow; and congestive heart failure, which usually does not occur unless the valve has been narrowed for many years.
- Valve replacement either with a mechanical valve made of metal or plastic or with a valve from a pig, may provide substantial relief from such valvular conditions.
- mitral stenosis In mitral stenosis, the valve opening between the upper and lower chambers on the left side of the heart has become narrowed. The cause is generally rheumatic fever, which is now rare in most developed countries but is common in many parts of the world, or results from other degenerative diseases and aging.
- mitral stenosis occurs, the narrow valve impedes the entry of blood into the left ventricle from the atrium. Pressure builds up behind the valve, leading to an elevation of pressure in the lungs. This in turn may lead to shortness of breath (dyspnea), which is one of the major symptoms of mitral stenosis. Often, however, it occurs without any symptoms.
- aortic regurgitation In aortic regurgitation, the aortic valve fails to close completely after the heart has pumped blood out into the aorta. Blood leaks back from the aorta into the left ventricle. In mitral regurgitation, improper closure causes blood to leak from the left ventricle back into the left atrium. In either case, the valve does not close properly because of a physical change in its shape or its support. This change may be the result of rheumatic fever; an infection (endocarditis), which may leave the valve scarred; or a heart attack, which causes loss of supporting muscle tissue.
- the change may be the result of a heart attack, which causes a loss of muscle tissue, or a spontaneous rupture of one of the muscular chords (chordea tendineae) that normally act as guide wires to keep the mitral valve in place.
- Medications such as digitalis, diuretics, and angiotensin- converting enzyme (ACE) inhibitors can help alleviate symptoms.
- ACE angiotensin- converting enzyme
- any narrowing is rare and almost always congenital. Leakage, or regurgitation, is unusual, but may occur when use of illicit intravenous drugs leads to infection that damages the valve.
- the infection hallmarked by fever, often settles on these two valves because they are the first ones bacteria come in contact with as they travel through the bloodstream. If the valve becomes leaky, swelling of the abdomen and legs may occur.
- treatment can include replacement, but this is rare and usually not as effective as it is when the aortic or mitral valve is involved.
- Drugs such as digitalis medications, vasodilators, diuretics, anticoagulants, and antiarrhythmics may be admimstered for valve disorders. Rather than being curative, however, the major functions of these drugs are to reduce the severity of the symptoms, possibly reduce the workload of the heart, and prevent complications.
- Balloon valvuloplasty may be used to correct narrowing of the mitral valve and occasionally the aortic valve by partially clearly obstructions.
- a deflated balloon attached to the end of a catheter is introduced through an artery into the heart to the center of the valve opening and then inflated.
- the inflated balloon presses back the calcium in the valve or corrects the anatomical deformity that has caused the narrowing.
- the diseased valve may be replaced with an artificial valve.
- Valve-replacement surgery is usually recommended when the damage to the valve is sever enough to be potentially life-threatening, as in the case of severe aortic stenosis.
- the mitral and aortic valves are the heart valves that most often need to be replaced. Artificial valves have been in use since 1952, when Charles Hufhagel successfully replaced a patient's aortic valve with a caged-ball valve.
- annuloplasty Another method for treating defective valves is through reconstruction, which is typically used on minimally calcified valves.
- One type of reconstructive surgery is known as annuloplasty.
- An annuloplasty is performed to correct mitral valve insufficiency and/or stenosis.
- Annuloplasty involves implanting an annuloplasty ring on the valve annulus.
- the annuloplasty ring is designed to support the functional changes that occur during the cardiac cycle: maintaining coaptation and valve integrity in systole while permitting good hemodynamics in diastole.
- the size of the valve annulus where the annuloplasty ring is to be implanted must be accurately measured. Sizing is achieved by measuring the width and the height of the anterior leaflet with sizing obturators or, in the vernacular, valve sizers. Once the size has been determined, a proper annuloplasty ring may be selected and implanted.
- FIGS. 1 and 2 A conventional annulus sizer currently used in annuloplasty surgery is illustrated in FIGS. 1 and 2 and is generally reference with numeral 10.
- the sizer 10 has a thickness T which is on the order of 0.28 inch and is made of a transparent polymer.
- the sizer 10 snaps onto a handle 12 with male and female couplers 14 and 16, respectively.
- the female coupler 16 is formed substantially in the centroid of the somewhat oval-shaped cross-section sizer 10, as shown in FIG. 2.
- the surgeon estimates the valve annulus size and selects a sizer accordingly.
- the sizer is snapped onto the end of the handle and guided into proximity with the annulus, which may involve passing the sizer through a relatively small access channel, especially in minimally invasive surgical procedures.
- the final seating of the sizer in the annulus may necessitate viewing the annulus through the transparent sizer, though the polymer material is not a perfect transmitter of light.
- the sizer thickness serves to provide tactile feedback to the surgeon for a range of depths of the annulus. That is, the surgeon often pushes the sizer well into the annulus to engage the entire side wall of the sizer, which tends to average the overall resistance to in-and-out movement, and is desired by some surgeons.
- the central location of the handle connection also balances moments imposed on the sizer as transmitted to the handle. If the sizer is not quite the right size, it is withdrawn and detached from the handle, being replaced by a different sizer.
- the sizer may be accidentally pried off the handle because of the snap fit, though the same attribute of ease of detachment is viewed as a plus to enable rapid switching of different sizers. Additionally, with the trend toward smaller and smaller access channels, the size of devices such as sizers and valves is becoming a limiting factor.
- annulus sizers which eliminate many of the drawbacks associated with conventional sizers.
- an annulus sizer includes a sizing portion with a coupling portion disposed on a proximal surface thereof.
- the sizing portion measures a valve annulus, and the coupling portion attaches to a handle.
- the sizing portion has a thickness on the order of about 0.1 inch.
- the relatively small thickness of the sizer facilitates minimally invasive annuloplasty surgery. For example, rather than accessing the heart through a sternotomy, a relatively small incision may be made intercostally through which the relatively thin sizer of the invention may be inserted.
- the relatively thin sizing portion minimizes optical distortion therethrough so that the surgeon is able to view the surgical field more clearly.
- the coupling portion may be disposed on the sizing portion at a location which is offset from the center of the sizer. Accordingly, an enlarged viewing area is defined on the sizing portion. Augmenting the advantages of low optical distortion, the enlarged viewing area enhances the surgeon's view of the surgical field.
- Another aspect of the invention involves securely attaching the sizer to a handle to prevent inadvertent detachment. This is accomplished by providing the coupling portion with threading to engage with threading of the handle.
- the threading preferably has a large pitch so that the sizer can be attached to the handle in just a couple of turns and in a secure and reliable manner. As time is of the essence during annuloplasty surgery, this secure yet quick attachment feature of the invention is particularly advantageous.
- FIG. 1 is a cross-sectional view of a conventional annulus sizer and handle end
- FIG. 2 is a plan view of the conventional annulus sizer
- FIG. 3 is a cross-sectional view of an exemplary annulus sizer and handle end for use during minimally invasive surgical procedures in accordance with the present invention, particularly illustrating a sizer for measuring a mitral valve annulus;
- FIG. 4 is a plan view of the annulus sizer of the invention
- FIG. 5 is a plan view of the annulus sizer of the invention, particularly illustrating a preferred handle attachment location which enhances visibility during minimally invasive procedures;
- FIG. 6 is a plan view of another exemplary annulus sizer of the present invention, particularly illustrating a sizer for measuring a tricuspid valve annulus;
- FIG. 7 is a diagrammatic view of a surgical implement for measuring annuluses during a minimally invasive procedure with a patient shown in cross section, particularly illustrating a step of entering a chest cavity intercostally;
- FIG. 8 is a view similar to that of FIG. 7, particularly illustrating a subsequent step in the minimally invasive annulus measuring procedure, particularly illustrating a sizer of the present invention within the chest cavity. DESCRIPTION OF THE PREFERRED EMODIMENTS
- FIG. 3 an exemplary embodiment of a valve sizer 20 of the present invention is illustrated in FIG. 3 in conjunction with a surgical handle 22.
- Exemplary sizer 20 includes a coupling portion 24 and a sizing portion 26.
- the coupling portion 24 includes structure for releasably attaching to the handle 22, which will be discussed in more detail below.
- the sizing portion 26 is utilized to determine the size of a valve annulus during annuloplasty surgery.
- Exemplary sizer 20 is configured to measure the annulus of a mitral valve, which will be discussed in more detail below.
- Exemplary sizing portion 26 is substantially flat and thin, with a distal surface 28, a proximal surface 30, and a thin peripheral side wall 32 extending between the surfaces. As shown, the coupling portion 24 is disposed on the proximal surface 30 of the sizing portion 26, and may be integrally molded together therewith. The sizing portion 26 has a thickness t that is substantially less than the thickness of conventional sizers, as discussed below.
- Exemplary sizer 20 is made from biocompatible material that is also preferably optically transparent and substantially rigid.
- An exemplary material for the sizer 20 is polysulfone, or other similar thermoplastic.
- the thickness t of the sizing portion 26 is preferably minimized while still retaining substantial strength to prevent substantial flexing or bending or to prevent breakage. Generally speaking, the thickness t of the sizing portion 26 may be less than about 0.2 inch but is preferably on the order of about 0.1 inch. Depending upon the material from which exemplary sizing portion 26 is made, the thickness t may be substantially less than 0.1 inch. In a commercial embodiment of the sizer 20, the thickness t is about 0.115 inch.
- exemplary sizer 20 of the present invention not only minimizes optical distortion but also facilitates insertion through small surgical openings common in minimally invasive procedures, an example of which will be discussed below.
- the sizing portion 26 of exemplary sizer 20 has a center C which may be defined as lying at the center of a line of symmetry dividing the substantially bean-shaped sizing portion 26.
- the line of symmetry is vertical in FIG. 5 and coincides with a line denoting a minor axis A min .
- the coupling portion 24 is preferably positioned on the sizing portion 26 at a location which is offset toward a concave edge of the sizing portion 26 from the center C. Accordingly, an enlarged viewing area is defined on the sizing portion 26.
- the enlarged viewing area is referenced by numeral 34 and is graphically represented in the drawings by the shaded area of the sizing portion 26.
- the location of the coupling portion 24 with respect to the sizing portion 26 may be generalized as offset away from a centroid, leaving a larger viewing area, such as indicated at 34.
- the particular bean shape of the present sizing portion 26 is exemplary only, and other sizer shapes are known.
- exemplary sizer 20 of the present invention greatly increases the percentage of the field of view which a surgeon may see.
- the enlarged viewing area 34 coupled with the minimal thickness t of the sizing portion 26 which minimizes optical distortion, enhances the ability of a surgeon to position the sizer in a valve annulus and to determine its size accurately.
- exemplary sizer 20 may be configured in any desired manner, it is preferable for the sizing portion 26 to have a shape which is analogous to the shape of a healthy valve annulus and/or the shape of an annuloplasty ring. Accordingly, the sizing portion 26 may be noncircular in shape. More specifically, the sizing portion 26 for mitral valve annuluses is typically shaped somewhat like a kidney bean and, as shown in FIG. 5, defines a major axis A maj and the aforementioned minor axis A min , which axes have an intersection I.
- the major axis A maJ is defined generally along the greater of the two dimensions of the sizer 20 (i.e., the horizontal dimension from apogee to apogee), and the minor axis A min is defined generally along the lesser of the two dimensions of the sizer 20 (i.e., the vertical dimension).
- the kidney-shaped mitral-valve sizer 20 shown in FIG. 5 is substantially symmetrical about the minor axis A min .
- the coupling portion 24 may be positioned on the sizing portion 26 substantially at or near the intersection I. In other words, the coupling portion 24 may have an axis N defined therethrough (see FIG.
- the coupling portion 24 may be offset from the center C.
- the coupling portion 24 is preferably offset from the center C along the minor axis A min and positioned substantially on the major axis A maj .
- the location at which the coupling portion 24 is disposed on the sizing portion 26 may be further offset from the center C along the minor axis A min toward the side wall 32.
- the coupling portion 24 may be offset from the center C in any direction (indiscriminate of the axis A maj and A min ) to define an enlarged viewing area on the sizing portion 26.
- the side wall 32 may have a plurality of different portions or segments defined therealong and separated by transitions in shape.
- the side wall 32 may have a concave side 36 and a convex side 38.
- the concave side 36 of the side wall 32 curves inwardly toward the center C at or near the minor axis A mm .
- the convex side 38 of the side wall 32 curves outwardly from the center C at or near the minor axis A mm .
- the coupling portion 24 may be positioned on the sizing portion 26 at a location which is closer to the concave side 36 than to the convex side 38 of the side wall 32.
- the sizing portion 26 has a length l maj defined along the major axis A maj and a length l m ⁇ n defined along the minor axis A m ⁇ n , with the major-axis length l maj being greater than the minor-axis length l m ⁇ n .
- the relationship between the respective magnitudes the major- and minor-axis lengths l maj and l m ⁇ n is preferably defined as a ratio of about 3:2 to about 4:3. More desirably, and stated a different way, the major-axis length l maj is about 1.2 to about 1.5 times greater than the minor-axis length l mn .
- Exemplary sizer 20 may be configured in accordance with other ratios of the lengths l maj and l m ⁇ n for use in specific valve-sizing applications.
- the major-axis length l maj corresponds to and is used to measure the width of the anterior leaflet of a valve
- the minor-axis length l m ⁇ n corresponds to and is used to measure the height of the anterior leaflet.
- a distance d which is defined as the distance the major axis A maj is from an apogee of the convex side 38 (i.e., the point at or near the intersection of the minor axis A mn and the convex side 38), may be used to further define the configuration of the sizing portion 26.
- the magnitude of the apogee distance d is greater than 50% of the minor-axis length l min and is preferably greater than at least 60% to 70% of the minor-axis length l min . In a preferred embodiment of a sizer 20 for measuring mitral- valve annuluses, the apogee distance d is about 65% of the minor-axis length l min .
- a plurality of sizers 20 of different dimensions is made available to a surgeon during an annuloplasty surgery, with each of the sizers corresponding to the size of an annuloplasty ring.
- annulus sizers are numbered according to the major-axis length l maJ in millimeters.
- the numbering system for mitral- annulus sizers includes 24, 26, 28 ... 40.
- a No. 36 sizer for example, may have a major-axis length l maj of about 1.5 inches, a minor- axis length l min of about 1.0 inch, and an apogee distance d of about 0.65 inch.
- the sizing portion 26 of exemplary sizer 20 for use in measuring a mitral valve annulus illustrated in FIG. 5 may be configured substantially asymmetrically as shown FIG. 6, which illustrates an exemplary embodiment of a valve annulus sizer of the invention for use in measuring a tricuspid valve annulus.
- Exemplary tricuspid sizer shown in FIG. 6 is indicated with numeral 20 with the addition of a prime (').
- the sizing portion 26' of exemplary tricuspid sizer 20' includes a substantially linear side 40 and an irregular convex side 42.
- the irregularly shaped convex side 42 provides an enlarged viewing area on the sizing portion 26'.
- the side wall 32 may taper from the distal surface 28 to the proximal surface 30.
- the tapered side wall 32 preferably angles outwardly so that the proximal surface 30 is larger than the distal surface 28.
- the edges 44 defined between the side wall 32 and each of the surfaces 28 and 30 is preferably rounded to be substantially atraumatic.
- the coupling portion 24 may be configured to be releasably attachable to the handle 22.
- the coupling portion 24 may include a threaded socket 46 for engaging with threading 48 disposed on a distal end of the handle 22.
- the threading 46 and 48 preferably has a pitch which allows the sizer 20 to engage securely with the handle 22 in relatively few turns, for example, two or three turns.
- the threading 46 and 48 may have a pitch of about 20 to 25 turns per inch.
- the coupling portion 24 preferably extends outwardly away from the proximal surface 30 of the sizing portion 26, thereby defining a tubular boss 50.
- a central channel 52 may extend through the coupling portion 24, as well as through the sizing portion 26.
- the coupling portion 24 may further include a pair of diametrically opposed planar surfaces 54, which are clearly shown in FIG. 4. Surfaces 54 may be used for grasping the sizer 20 with a tool other than the handle 22, for example, with a forceps.
- the sizing portion 26 desirably includes cross hairs 56 formed on the proximal surface 30 to aid in making vertical and horizontal measurements in a valve annulus.
- the sizing portion 26 may include a pair of notches 57 corresponding to the commissures of a valve annulus for purposes of locating and orienting the sizing portion 26 in the valve annulus.
- exemplary sizer 20 of the present invention is particularly useful in minimally invasive procedures.
- annuloplasty surgery a plurality of annuloplasty rings, each of a different size as known in the art, are provided. A plurality of sizers 20 are also made available to the surgeon. Each of the sizers 20 has a size corresponding to one of the annuloplasty rings.
- FIGS. 7 and 8 the heart of the patient is then accessed, which may be carried out through any type of conventional sternotomy or through a mini-thoracotomy. Access to the chest cavity is preferably accomplished in a minimally invasive manner, for example, through an intercostal incision 60 which defines an opening 62 between adjacent ribs 64 and 646.
- a retractor or a trocar may be employed to maintain patency of the opening 62.
- cartilage may be removed in forming the opening 62, if desired and as known in the art.
- the surgeon may then access the heart and the valve annulus of the defective valve.
- the valve annulus needs to be measured to select a properly sized annuloplasty ring.
- one of the sizers is selected and positioned in the annulus. If the surgeon determines that this is not a proper sizer, another differently sized sizer may be selected and positioned in the annulus. This process, which is discussed in detail below, may be repeated until the surgeon determines the size of the annulus.
- the handle 22 is preferably made from a malleable material so that a bend 66 may be formed in the handle 22 to facilitate the procedure.
- the size of the opening 62 is preferably minimized.
- the opening 62 preferably has a length l 0 which is less than the minor- axis width l min of the sizing portion 26; for example, length l 0 may be less than about an inch or, more preferably, less than about three-quarters of an inch.
- the sizer 20 may be tilted obliquely to the opening 62 and then inserted through the opening 62, with the convex side 38 defining a leading edge.
- the sizer 20 may be tilted in a reverse manner while urging the concave portion 36 (which defines a trailing edge) through the opening 62.
- the sizer 20 may be positioned on or above the valve annulus to determine its size.
- the enlarged viewing area 34 enhances the surgeon's ability to view the surgical field with or without visual aids.
- the sizer 20 may be removed from the patient by essentially reversing the foregoing insertion procedure.
- the minimized thickness t of the sizing portion 26 facilitates the insertion and the removal of the sizer 20 through the relatively narrow opening 62.
- the surgeon's field of view is limited by the size of the opemng 62, he or she may look through the transparent sizing portion 26 with minimal distortion.
- the threaded connection between the coupling portion 26 and the handle 22 ensures a secure attachment, which is beneficial in tight minimally invasive working environments. For example, pressure may be applied on the sizer 20 while being removed through the opening 62, which pressure could possibly disengage conventionally attached sizers.
- the large pitch of the threading 46 and 48 allows the surgeon to quickly remove and reattach different sizers in a secure and reliable manner.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/099,732 US6019739A (en) | 1998-06-18 | 1998-06-18 | Minimally invasive valve annulus sizer |
| US99732 | 1998-06-18 | ||
| PCT/US1999/013774 WO1999065423A1 (en) | 1998-06-18 | 1999-06-18 | Minimally invasive valve annulus sizer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1087730A1 true EP1087730A1 (de) | 2001-04-04 |
| EP1087730B1 EP1087730B1 (de) | 2004-09-29 |
Family
ID=22276358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP99928786A Expired - Lifetime EP1087730B1 (de) | 1998-06-18 | 1999-06-18 | Minimalinvasives messinstrument für einen herzventilverankerungsring |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6019739A (de) |
| EP (1) | EP1087730B1 (de) |
| JP (1) | JP2002518089A (de) |
| AT (1) | ATE277570T1 (de) |
| AU (1) | AU758852B2 (de) |
| CA (1) | CA2334835C (de) |
| DE (1) | DE69920694T2 (de) |
| WO (1) | WO1999065423A1 (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6967998B1 (en) | 1999-11-12 | 2005-11-22 | Qualcomm Incorporated | Method and apparatus for monitoring transmission quality |
Families Citing this family (107)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE514718C2 (sv) * | 1999-06-29 | 2001-04-09 | Jan Otto Solem | Anordning för behandling av bristande tillslutningsförmåga hos mitralisklaffapparaten |
| US6997951B2 (en) * | 1999-06-30 | 2006-02-14 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
| US7192442B2 (en) * | 1999-06-30 | 2007-03-20 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
| US6598307B2 (en) * | 1999-11-17 | 2003-07-29 | Jack W. Love | Device and method for assessing the geometry of a heart valve |
| US6678962B1 (en) | 1999-11-17 | 2004-01-20 | Cardiomend Llc | Device and method for assessing the geometry of a heart valve |
| US7507252B2 (en) * | 2000-01-31 | 2009-03-24 | Edwards Lifesciences Ag | Adjustable transluminal annuloplasty system |
| US6402781B1 (en) * | 2000-01-31 | 2002-06-11 | Mitralife | Percutaneous mitral annuloplasty and cardiac reinforcement |
| US7199102B2 (en) * | 2000-08-24 | 2007-04-03 | The Regents Of The University Of California | Orally administered peptides synergize statin activity |
| US8568766B2 (en) | 2000-08-24 | 2013-10-29 | Gattadahalli M. Anantharamaiah | Peptides and peptide mimetics to treat pathologies associated with eye disease |
| US7148197B2 (en) * | 2000-08-24 | 2006-12-12 | The Regents Of The University Of California | Orally administered small peptides synergize statin activity |
| US7723303B2 (en) * | 2000-08-24 | 2010-05-25 | The Regents Of The University Of California | Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| US7510576B2 (en) * | 2001-01-30 | 2009-03-31 | Edwards Lifesciences Ag | Transluminal mitral annuloplasty |
| US6810882B2 (en) * | 2001-01-30 | 2004-11-02 | Ev3 Santa Rosa, Inc. | Transluminal mitral annuloplasty |
| US6681773B2 (en) * | 2001-02-28 | 2004-01-27 | Chase Medical, Inc. | Kit and method for use during ventricular restoration |
| US20030181940A1 (en) * | 2001-02-28 | 2003-09-25 | Gregory Murphy | Ventricular restoration shaping apparatus and method of use |
| US20020133227A1 (en) * | 2001-02-28 | 2002-09-19 | Gregory Murphy | Ventricular restoration patch apparatus and method of use |
| US6955689B2 (en) * | 2001-03-15 | 2005-10-18 | Medtronic, Inc. | Annuloplasty band and method |
| US6786924B2 (en) * | 2001-03-15 | 2004-09-07 | Medtronic, Inc. | Annuloplasty band and method |
| ITMI20011012A1 (it) | 2001-05-17 | 2002-11-17 | Ottavio Alfieri | Protesi anulare per valvola mitrale |
| US7935145B2 (en) * | 2001-05-17 | 2011-05-03 | Edwards Lifesciences Corporation | Annuloplasty ring for ischemic mitral valve insuffuciency |
| US7367991B2 (en) * | 2001-08-28 | 2008-05-06 | Edwards Lifesciences Corporation | Conformal tricuspid annuloplasty ring and template |
| US6908482B2 (en) | 2001-08-28 | 2005-06-21 | Edwards Lifesciences Corporation | Three-dimensional annuloplasty ring and template |
| US20040243170A1 (en) * | 2001-09-05 | 2004-12-02 | Mitta Suresh | Method and device for percutaneous surgical ventricular repair |
| US7485088B2 (en) * | 2001-09-05 | 2009-02-03 | Chase Medical L.P. | Method and device for percutaneous surgical ventricular repair |
| US6805710B2 (en) * | 2001-11-13 | 2004-10-19 | Edwards Lifesciences Corporation | Mitral valve annuloplasty ring for molding left ventricle geometry |
| DE60235834D1 (de) * | 2001-12-28 | 2010-05-12 | Edwards Lifesciences Ag | Speichervorrichtung mit Verzögerung |
| SE524709C2 (sv) * | 2002-01-11 | 2004-09-21 | Edwards Lifesciences Ag | Anordning för fördröjd omformning av ett hjärtkärl och en hjärtklaff |
| EP1646332B1 (de) * | 2003-07-18 | 2015-06-17 | Edwards Lifesciences AG | Fernaktiviertes Mitral-Annuloplastie-System |
| US20050177228A1 (en) * | 2003-12-16 | 2005-08-11 | Solem Jan O. | Device for changing the shape of the mitral annulus |
| ITTO20040135A1 (it) | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | Protesi valvolare cardiaca |
| US7993397B2 (en) * | 2004-04-05 | 2011-08-09 | Edwards Lifesciences Ag | Remotely adjustable coronary sinus implant |
| US7452376B2 (en) * | 2004-05-14 | 2008-11-18 | St. Jude Medical, Inc. | Flexible, non-planar annuloplasty rings |
| EP1761211B1 (de) * | 2004-05-14 | 2013-08-28 | St. Jude Medical, Inc. | Halte- und Stützvorrichtung für einen Annuloplastiering |
| US7938856B2 (en) * | 2004-05-14 | 2011-05-10 | St. Jude Medical, Inc. | Heart valve annuloplasty prosthesis sewing cuffs and methods of making same |
| US20050278022A1 (en) * | 2004-06-14 | 2005-12-15 | St. Jude Medical, Inc. | Annuloplasty prostheses with improved anchoring structures, and related methods |
| US20060095048A1 (en) * | 2004-10-29 | 2006-05-04 | Zannis Anthony D | Method of repairing soft tissue using sizing templates |
| JP2008522980A (ja) * | 2004-12-06 | 2008-07-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 小血管の構造および機能を改善するための方法 |
| US7211110B2 (en) * | 2004-12-09 | 2007-05-01 | Edwards Lifesciences Corporation | Diagnostic kit to assist with heart valve annulus adjustment |
| US20060167386A1 (en) * | 2005-01-24 | 2006-07-27 | Drake Daniel H | Blood vessel graft sizer |
| ITTO20050074A1 (it) | 2005-02-10 | 2006-08-11 | Sorin Biomedica Cardio Srl | Protesi valvola cardiaca |
| US7575595B2 (en) | 2005-03-23 | 2009-08-18 | Edwards Lifesciences Corporation | Annuloplasty ring and holder combination |
| US7842085B2 (en) * | 2005-03-23 | 2010-11-30 | Vaso Adzich | Annuloplasty ring and holder combination |
| US20080293639A1 (en) * | 2005-04-29 | 2008-11-27 | The Regents Of The University Of California | Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| KR20080007491A (ko) * | 2005-04-29 | 2008-01-21 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 염증성 반응을 특징으로 하는 병리를 치료하기 위한 펩티드및 펩티드 모방체 |
| US7500989B2 (en) * | 2005-06-03 | 2009-03-10 | Edwards Lifesciences Corp. | Devices and methods for percutaneous repair of the mitral valve via the coronary sinus |
| US8685083B2 (en) * | 2005-06-27 | 2014-04-01 | Edwards Lifesciences Corporation | Apparatus, system, and method for treatment of posterior leaflet prolapse |
| US20070038297A1 (en) * | 2005-08-12 | 2007-02-15 | Bobo Donald E Jr | Medical implant with reinforcement mechanism |
| US20080221673A1 (en) * | 2005-08-12 | 2008-09-11 | Donald Bobo | Medical implant with reinforcement mechanism |
| US20070073391A1 (en) * | 2005-09-28 | 2007-03-29 | Henry Bourang | System and method for delivering a mitral valve repair device |
| JP5361392B2 (ja) * | 2005-12-15 | 2013-12-04 | ジョージア テック リサーチ コーポレイション | 心臓弁置換術を可能にするシステム及び方法 |
| JP2009519784A (ja) | 2005-12-15 | 2009-05-21 | ジョージア テック リサーチ コーポレイション | 心臓弁の寸法を制御するシステム及び方法 |
| US9125742B2 (en) | 2005-12-15 | 2015-09-08 | Georgia Tech Research Foundation | Papillary muscle position control devices, systems, and methods |
| JP5258754B2 (ja) * | 2006-05-15 | 2013-08-07 | エドワーズ・ライフサイエンシス・アーゲー | 心臓の幾何学的形状を変更するシステムおよび方法 |
| US7815676B2 (en) * | 2006-07-07 | 2010-10-19 | The Cleveland Clinic Foundation | Apparatus and method for assisting in the removal of a cardiac valve |
| US20080058924A1 (en) * | 2006-09-01 | 2008-03-06 | Aaron Ingle | Saddle-shaped annuloplasty ring |
| US20080065205A1 (en) * | 2006-09-11 | 2008-03-13 | Duy Nguyen | Retrievable implant and method for treatment of mitral regurgitation |
| US7879087B2 (en) | 2006-10-06 | 2011-02-01 | Edwards Lifesciences Corporation | Mitral and tricuspid annuloplasty rings |
| WO2008098226A1 (en) * | 2007-02-09 | 2008-08-14 | Edwards Lifesciences Corporation | Progressively sized annuloplasty rings |
| US20080255447A1 (en) * | 2007-04-16 | 2008-10-16 | Henry Bourang | Diagnostic catheter |
| US20080262603A1 (en) * | 2007-04-23 | 2008-10-23 | Sorin Biomedica Cardio | Prosthetic heart valve holder |
| US8006535B2 (en) | 2007-07-12 | 2011-08-30 | Sorin Biomedica Cardio S.R.L. | Expandable prosthetic valve crimping device |
| US8100820B2 (en) | 2007-08-22 | 2012-01-24 | Edwards Lifesciences Corporation | Implantable device for treatment of ventricular dilation |
| CA2704729C (en) * | 2007-08-28 | 2020-06-23 | Uab Research Foundation | Synthetic apolipoprotein e mimicking polypeptides and methods of use |
| CA2697957A1 (en) | 2007-08-28 | 2009-03-12 | Uab Research Foundation | Synthetic apolipoprotein e mimicking polypeptides and methods of use |
| CN103393485B (zh) | 2007-09-07 | 2016-08-10 | 爱德华兹生命科学公司 | 用于输送瓣环成形术环的活动支架 |
| US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
| US7993395B2 (en) * | 2008-01-25 | 2011-08-09 | Medtronic, Inc. | Set of annuloplasty devices with varying anterior-posterior ratios and related methods |
| JP5390597B2 (ja) * | 2008-05-09 | 2014-01-15 | エドワーズ ライフサイエンシーズ コーポレイション | 変性弁膜症に特有の弁形成リング |
| US20090287303A1 (en) | 2008-05-13 | 2009-11-19 | Edwards Lifesciences Corporation | Physiologically harmonized tricuspid annuloplasty ring |
| US8834563B2 (en) | 2008-12-23 | 2014-09-16 | Sorin Group Italia S.R.L. | Expandable prosthetic valve having anchoring appendages |
| US9028544B2 (en) * | 2009-02-06 | 2015-05-12 | St. Jude Medical, Inc. | Robotic heart valve annulus sizer |
| US8715207B2 (en) * | 2009-03-19 | 2014-05-06 | Sorin Group Italia S.R.L. | Universal valve annulus sizing device |
| ES2543460T3 (es) | 2009-03-26 | 2015-08-19 | Sorin Group Usa, Inc. | Dispositivos de dimensionamiento de anuloplastia para intervenciones mínimamente invasivas |
| US20110022165A1 (en) | 2009-07-23 | 2011-01-27 | Edwards Lifesciences Corporation | Introducer for prosthetic heart valve |
| IT1400327B1 (it) | 2010-05-21 | 2013-05-24 | Sorin Biomedica Cardio Srl | Dispositivo di supporto per protesi valvolari e corrispondente corredo. |
| US9592008B2 (en) * | 2010-07-01 | 2017-03-14 | Pulmonx Corporation | Devices and systems for lung treatment |
| US10524911B2 (en) | 2010-08-24 | 2020-01-07 | Edwards Lifesciences Corporation | Flexible annuloplasty ring with select control points |
| BR112013007494B1 (pt) | 2010-08-31 | 2020-11-10 | Edwards Lifesciences Corporation | anel de anuloplastia tricúspide protético |
| US8932350B2 (en) | 2010-11-30 | 2015-01-13 | Edwards Lifesciences Corporation | Reduced dehiscence annuloplasty ring |
| EP2486894B1 (de) | 2011-02-14 | 2021-06-09 | Sorin Group Italia S.r.l. | Vorrichtung zur nahtlosen Verankerung von Herzklappenprothesen |
| ES2641902T3 (es) | 2011-02-14 | 2017-11-14 | Sorin Group Italia S.R.L. | Dispositivo de anclaje sin sutura para prótesis valvulares cardiacas |
| US11213393B2 (en) | 2011-04-01 | 2022-01-04 | Edwards Lifesciences Corporation | Compressible heart valve annulus sizing templates |
| ES2392416B1 (es) * | 2011-05-06 | 2013-08-06 | Anas SARRAJ ASIL | Kit para anuloplastia de la válvula tricúspide. |
| US8920493B2 (en) | 2011-09-16 | 2014-12-30 | St. Jude Medical, Cardiology Division, Inc. | Systems and methods for holding annuloplasty rings |
| US10182913B2 (en) | 2012-10-12 | 2019-01-22 | Nikola Dobrilovic | Heart valve sizing ring for valve-sparing aortic root remodeling procedures |
| US11872135B2 (en) | 2012-10-12 | 2024-01-16 | Nikola Dobrilovic, LLC | Heart valve sizing ring for valve-sparing aortic root remodeling procedures |
| US9889009B2 (en) | 2011-10-26 | 2018-02-13 | Nikola Dobrilovic | Heart valve sizing ring and method |
| US9345574B2 (en) | 2011-12-09 | 2016-05-24 | Edwards Lifesciences Corporation | Force-based heart valve sizer |
| US9277996B2 (en) | 2011-12-09 | 2016-03-08 | Edwards Lifesciences Corporation | Force-based heart valve sizer |
| US9763783B2 (en) | 2012-04-27 | 2017-09-19 | Nikola Dobrilovic | Prosthetic device for heart valve reinforcement and remodeling procedures |
| US9149360B2 (en) | 2013-03-12 | 2015-10-06 | Edwards Lifesciences Corporation | Dynamic annuloplasty ring sizer |
| US9687346B2 (en) | 2013-03-14 | 2017-06-27 | Edwards Lifesciences Corporation | Multi-stranded heat set annuloplasty rings |
| WO2015066814A1 (en) * | 2013-11-08 | 2015-05-14 | Dumaine Precision Inc. | Surgical cavity sizers for brachytherapy and intraoperative radiation therapy |
| US10653747B2 (en) | 2014-07-31 | 2020-05-19 | Uab Research Foundation | ApoE mimetic peptides and higher potency to clear plasma cholesterol |
| WO2016022797A1 (en) | 2014-08-06 | 2016-02-11 | Edwards Lifesciences Corporation | Multi-lumen cannulae |
| US10314707B2 (en) | 2015-06-09 | 2019-06-11 | Edwards Lifesciences, Llc | Asymmetric mitral annuloplasty band |
| EP3691541B1 (de) | 2017-10-07 | 2025-04-23 | Corcym S.r.l. | Biegbare chirurgische herzinstrumente |
| WO2019147497A1 (en) | 2018-01-23 | 2019-08-01 | Edwards Lifesciences Corporation | Prosthetic valve holders, systems, and methods |
| JP7074930B2 (ja) | 2018-05-23 | 2022-05-24 | コーシム・ソチエタ・ア・レスポンサビリタ・リミタータ | 心臓弁プロテーゼの原位置送達のためのデバイス |
| EP3796867B1 (de) | 2018-05-23 | 2024-12-25 | Corcym S.r.l. | Halter für eine herzklappenprothese, eine speicheranordnung für eine herzklappenprothese sowie crimpkit und verfahren |
| CA3101165A1 (en) | 2018-05-23 | 2019-11-28 | Sorin Group Italia S.R.L. | A cardiac valve prosthesis |
| CA3101103A1 (en) | 2018-05-23 | 2019-11-28 | Sorin Group Italia S.R.L. | A loading system for an implantable prosthesis and related loading method |
| WO2019241301A1 (en) * | 2018-06-11 | 2019-12-19 | Mccarthy Patrick M | Annuloplasty ring sizer |
| USD908874S1 (en) | 2018-07-11 | 2021-01-26 | Edwards Lifesciences Corporation | Collapsible heart valve sizer |
| CN112437651B (zh) | 2018-07-30 | 2024-01-16 | 爱德华兹生命科学公司 | 微创低应变瓣环成形术环 |
| CA3117368A1 (en) * | 2018-11-01 | 2020-05-07 | Edwards Lifesciences Corporation | Annuloplasty ring assembly with detachable handle |
| WO2021252754A1 (en) * | 2020-06-11 | 2021-12-16 | Lsi Solutions, Inc. | Surgical sizer sound |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2083362B (en) * | 1977-12-29 | 1982-11-24 | Yeshiva University Albert Eins | Disposable heart valve unit |
| US4211241A (en) * | 1978-03-03 | 1980-07-08 | Kastec Corporation | Heart valve sizing gauge |
| US4388735A (en) * | 1980-11-03 | 1983-06-21 | Shiley Inc. | Low profile prosthetic xenograft heart valve |
| US4626255A (en) * | 1983-09-23 | 1986-12-02 | Christian Weinhold | Heart valve bioprothesis |
| US5042161A (en) * | 1985-10-07 | 1991-08-27 | Joseph Hodge | Intravascular sizing method and apparatus |
| US5290300A (en) * | 1989-07-31 | 1994-03-01 | Baxter International Inc. | Flexible suture guide and holder |
| US5163955A (en) * | 1991-01-24 | 1992-11-17 | Autogenics | Rapid assembly, concentric mating stent, tissue heart valve with enhanced clamping and tissue alignment |
| EP0596981B1 (de) * | 1991-08-02 | 1997-09-03 | Baxter International Inc. | Biegsame naehfadenfuehrung und halterung |
| US5814097A (en) * | 1992-12-03 | 1998-09-29 | Heartport, Inc. | Devices and methods for intracardiac procedures |
| US5403305A (en) * | 1993-04-08 | 1995-04-04 | Carbomedics, Inc. | Mitral valve prosthesis rotator |
| US5360014A (en) * | 1993-11-10 | 1994-11-01 | Carbomedics, Inc. | Sizing apparatus for heart valve with supra annular suture ring |
| US5489296A (en) * | 1993-12-17 | 1996-02-06 | Autogenics | Heart valve measurement tool |
| US5531785A (en) * | 1994-05-06 | 1996-07-02 | Autogenics, Inc. | Prosthetic heart valve holder |
| US5814098A (en) * | 1995-06-07 | 1998-09-29 | St. Jude Medical, Inc. | Adjustable sizing apparatus |
| WO1997025003A1 (en) * | 1996-01-05 | 1997-07-17 | Baxter International Inc. | Sizing obturator for prosthetic aortic valves |
| US5843177A (en) * | 1996-05-02 | 1998-12-01 | St. Jude Medical, Inc. | Apparatus for attaching a handle to an annuloplasty ring implantation device |
| US5885228A (en) * | 1996-05-08 | 1999-03-23 | Heartport, Inc. | Valve sizer and method of use |
| JP4234212B2 (ja) * | 1997-05-29 | 2009-03-04 | エドワーズ ライフサイエンシーズ コーポレイション | 形状調節可能な外科手術用器具ハンドル |
-
1998
- 1998-06-18 US US09/099,732 patent/US6019739A/en not_active Expired - Lifetime
-
1999
- 1999-06-18 EP EP99928786A patent/EP1087730B1/de not_active Expired - Lifetime
- 1999-06-18 WO PCT/US1999/013774 patent/WO1999065423A1/en not_active Ceased
- 1999-06-18 AT AT99928786T patent/ATE277570T1/de not_active IP Right Cessation
- 1999-06-18 CA CA002334835A patent/CA2334835C/en not_active Expired - Lifetime
- 1999-06-18 DE DE69920694T patent/DE69920694T2/de not_active Expired - Lifetime
- 1999-06-18 AU AU45773/99A patent/AU758852B2/en not_active Expired
- 1999-06-18 JP JP2000554305A patent/JP2002518089A/ja not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| See references of WO9965423A1 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6967998B1 (en) | 1999-11-12 | 2005-11-22 | Qualcomm Incorporated | Method and apparatus for monitoring transmission quality |
Also Published As
| Publication number | Publication date |
|---|---|
| DE69920694T2 (de) | 2005-10-13 |
| EP1087730B1 (de) | 2004-09-29 |
| US6019739A (en) | 2000-02-01 |
| WO1999065423A1 (en) | 1999-12-23 |
| ATE277570T1 (de) | 2004-10-15 |
| CA2334835A1 (en) | 1999-12-23 |
| JP2002518089A (ja) | 2002-06-25 |
| AU4577399A (en) | 2000-01-05 |
| AU758852B2 (en) | 2003-04-03 |
| CA2334835C (en) | 2005-11-08 |
| DE69920694D1 (de) | 2004-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6019739A (en) | Minimally invasive valve annulus sizer | |
| CA2381820C (en) | Methods and apparatus for measuring valve annuluses during heart valve-replacement surgery | |
| US11883295B2 (en) | Methods of dynamic annuloplasty ring sizing | |
| EP1258232B1 (de) | Ringprothese für eine Mitralklappe | |
| US10130472B2 (en) | Devices and methods for treating valvular regurgitation | |
| JP4291142B2 (ja) | 三次元弁形成リングおよびテンプレート | |
| US20030050693A1 (en) | Minimally invasive delivery system for annuloplasty rings | |
| US20130030522A1 (en) | Devices and methods for heart treatments | |
| KR20020064878A (ko) | 승모판 윤성형링 및 방법 | |
| JP2004510493A (ja) | 最小侵襲性の弁輪形成修復セグメント送達テンプレートシステム | |
| GB2548891A (en) | A prosthetic device for mitral valve repair | |
| US20250213847A1 (en) | Implantable heart pump systems including an improved apical connector and/or graft connector | |
| CN210121193U (zh) | 一种瓣膜修复夹体 | |
| US7441342B2 (en) | System and method for sizing a heart for treating congestive heart failure | |
| US20060247764A1 (en) | System and method for sizing a heart for treating congestive heart failure | |
| Volpi et al. | Minimally Invasive Mitral Valve Surgery Using the FlexCrown Retractor: A Safe and Effective New Self-Expandable Left Atrial Exposure Device | |
| JP2022506186A (ja) | 可撓性シャフトを有するリングホルダーを備える弁輪形成リングアセンブリ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20010111 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: EDWARDS LIFESCIENCES CORPORATION |
|
| 17Q | First examination report despatched |
Effective date: 20030415 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040929 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040929 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040929 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20040929 |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: KIRKER & CIE SA |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REF | Corresponds to: |
Ref document number: 69920694 Country of ref document: DE Date of ref document: 20041104 Kind code of ref document: P |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20041229 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20041229 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20041229 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050109 |
|
| NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20050618 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050618 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20050620 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20050630 |
|
| ET | Fr: translation filed | ||
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20050630 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20050228 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 18 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 19 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20180522 Year of fee payment: 20 Ref country code: CH Payment date: 20180528 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20180523 Year of fee payment: 20 Ref country code: FR Payment date: 20180525 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20180522 Year of fee payment: 20 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69920694 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20190617 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20190617 |